Ellectis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ellectis inc . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ellectis Inc Today - Breaking & Trending Today

Monthly information on share capital and company voting

(Article 223-16 of General Regulation of the French financial markets authority). ....

France General , Patricia Sosa Navarro , Arthur Stril , Ashleyr Robinson , Sosa Navarro , Chief Business Officer , Lifesci Advisors , Paris Stock Exchange Alcls , Ellectis Inc , Ar T ,

Cellectis Appoints Dr. Cécile Chartier, Ph.D. to its Board

NEW YORK, July 12, 2023 (GLOBE NEWSWIRE) Cellectis S.A. (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company. ....

France General , North Carolina , United States , New York , Arthur Stril , Ashleyr Robinson , Pascalyne Wilson , Louis Pasteur , Nextvivo Inc , Company Board Of Directors , Research At Iovance Biotherapeutics Inc , Harvard Medical School , Oncomed Pharmaceuticals , Company Euronext Growth , Securities Exchange Commission , Euronext Growth , Cellecti Board , Chief Executive Officer , Chief Scientific Officer , Vice President , Senior Director , Target Validation , Harvard Medical , Nasdaq Global Market , Private Securities Litigation Reform Act , Annual Report ,

Cellectis Presents Updated Clinical and Translational Data

NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company. ....

New York , United States , France General , North Carolina , Pascalyne Wilson , Ashleyr Robinson , Nicolas Boissel , Arthur Stril , American Society Of Hematology , Securities Exchange Commission , Cellectis The Company Euronext Growth , European Hematology Association , Euronext Growth , Hematology Adolescent , Young Adult Unit , Intermediate Dose Level , American Society , Dose Level , Nasdaq Global Market , Private Securities Litigation Reform Act , Annual Report , Chief Business Officer , Lifesci Advisors , Paris Stock Exchange Alcls , Ellectis Inc , Ar T ,

Cellectis to Host a Live Webcast and Provide a Company

NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company. ....

New York , United States , France General , North Carolina , Ashleyr Robinson , Margaret Gandolfo , Arthur Stril , Pascalyne Wilson , Cellectis The Company Euronext Growth , Securities Exchange Commission , Euronext Growth , Nasdaq Global Market , Senior Manager , Chief Business Officer , Lifesci Advisors , Private Securities Litigation Reform Act , Annual Report , Paris Stock Exchange Alcls , Ellectis Inc ,

Cellectis Provides Business Update and Reports Financial

ASH 2022 sponsored programs – UCART123 abstract selected for oral presentation & preclinical data on UCARTCS1 selected for poster presentation, in. ....

United States , Noord Holland , Mark Frattini , Iovance Biotherapeutics , American Society Of Hematology , Clinical Development Programs , Iovance Biotherapeutics Inc , American Society Of Hematology Annual Meeting , Amsterdam University Medical Center , Amsterdam University Medical , Allogene Therapeutics , Chief Medical , Euronext Growth , American Society , Hematology Annual , Chief Executive Officer , Cellectis Sponsored Phase , Paris Stock Exchange Alcls , Ellectis Inc ,